Clinical trials
Recruiting Phase 1 Myelodysplastic Syndromes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 8 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 12 |
| 2025 | 12 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 62 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 5 |
| Dana-Farber Cancer Institute | 4 |
| Montefiore Medical Center | 3 |
| Fred Hutchinson Cancer Center | 2 |
| M.D. Anderson Cancer Center | 2 |
| Mayo Clinic | 2 |
| National Cancer Institute (NCI) | 2 |
| Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 |
| Stanford University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 62 |
| Leukemia, Myeloid, Acute | 52 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 14 |
| Leukemia, Myelomonocytic, Chronic | 11 |
| Primary Myelofibrosis | 7 |
| Hematologic Neoplasms | 6 |
| Leukemia | 6 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 6 |
| Graft vs Host Disease | 5 |
| Leukemia, Biphenotypic, Acute | 5 |
Trials
Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.